Ex-Sandoz Official To Lead Alembic's US Front End
This article was originally published in Scrip
Executive Summary
India's Alembic Pharmaceuticals has put in place its core leadership team in the US, which includes two ex-Sandoz officials, as it moves towards setting up its own front-end there.
You may also be interested in...
Former Sandoz Executive Kellum Admits US Price-Fixing
Former Sandoz executive Hector Armando Kellum has admitted involvement in a US generic price-fixing conspiracy, the US Department of Justice has announced.
Alembic Setting Up For US Oncology Play
Alembic Pharmaceuticals, which has seen a dazzling FY16, appears set to build on its strong showing in the US with plans for filings in the oncology and dermatology space and a potential ramp up of its own label products there.
How Sanofi Is ‘Playing To Win’ In India, Watch Diabetes Space
Sanofi India managing director Rodolfo Hrosz talks to Scrip about the company’s refreshed India strategy including in the competitive diabetes segment, which is expected to see a flurry of new product activity. While Soliqua has hit the market, all eyes are also on Novo Nordisk’s Awiqli and Cipla’s partnered inhaled insulin in the wings.